This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
It is possible to produce 4th generation of drugs against CML.
Prof. Yijun Chen
China Pharmaceutical University
This page is a summary of: Discovery of a small molecule targeting SET-PP2A interaction to overcome BCR-ABLT315I mutation of chronic myeloid leukemia, Oncotarget, May 2015, Impact Journals, LLC,
DOI: 10.18632/oncotarget.3665.
You can read the full text:
The following have contributed to this page
Clinical and Translational Science
Mannitol is a potentially very effective colonoscopy preparation that is very well accepted by patients. For the first time, a pharmacokinetic study was carried out on different dosages of mannitol...
Urologic Oncology Seminars and Original Investigations
The glutathione-S-transferases (GSTs) comprise a class of enzymes that detoxify carcinogenic compounds by conjugating glutathione to facilitate their removal. Polymorphisms in GSTM1, GSTT1, and GST...
F1000Research
The knowledge of management algorithms for cardiorespiratory arrest among health workers is of utmost importance, however, the result of cardiopulmonary resuscitation has remained deficient. Theref...
